Thursday, May 10, 2018 1:19:45 PM
TCEL DD Research Package -* Must Read*
The recent stock activity of TCEL coupled to the recent reinstatement of TCEL with Wyoming SOS, along with WE HAVE UNCOVERED BRAND NEW PATENTS & A BRAND NEW COMPANY (Fission Biomedical LLC and ContraVaccine LTD.) Strongly Suggesting that the research by Dr. Casey has been going full speed ahead behind the scenes.
The Reinstatement also suggests that along with all these new developments, there is news on the horizon of possible FDA approval for human trials for Therapy Cells & the possibility and bringing Mr. Casey's new company which shares TCEL Patents into the company as well maybe as an acquisition or Reverse Merger. Below is the research that would explain the current stock action and resurgence of volume and accumulation interest:
Therapy Cells, Inc. is a holding company. Their primary business focus and direction is applying Patent 8372644 and pursuing Therapy Cell related business. The company owned by Dr. Patrick Casey, Therapy Cells Limited (TCL), a New Zealand Corporation, was acquired by Therapy Cells Inc. (USA ) in August of 2011 for 3,000,000 Preferred C shares.
Therapy Cells, Inc. has been granted exclusive license to use Patent 8372644 for use in human applications. In 2013, the company had to cease trials due to lack of funding. The funding was in place in September 2015 via Soffinova Partners:
http://www.marketwired.com/press-release/therapy-cells-receives-funding-from-sofinnova-partners-advance-development-tissue-organ-otcqb-tcel-2057891.htm
The company has been quietly completing their research since! It's possible there were delays in receiving some of the funding, since it was coming from overseas (Paris), and it likely gets received as needed. Some NEW good news, just out last month from Sofinnova Partners, is that they have new funding for Biotech and Pharmaceutical companies estimated to be at least $375 million. Therapy Cell, Inc. in past PR stated that this was a long term funding agreement - as research is not a Fast process but an approach to science that requires tenacity and hard work, and the funding matter has to be out of the way which it has been during this time of dedicated silence in our opinion:
https://www.businesswire.com/news/home/20180403005874/en/Sofinnova-Partners-Launches-Healthcare-Crossover-Fund-%E2%82%AC275
Dr. Patrick Casey, who owns 3,000,000 preferred C shares via Therapy Cells, Limited (New Zealand) is also one of three beneficiary stockholders in Therapy Cells, Inc. He has been active.
In 2017 Casey was granted another NEW patent :
THIS YEAR In 2018, he applied for another new patent:
THE BIGGEST INTRIGUING NEWS IS THIS RECENT ACTIVITY: Dr. Patrick J. Casey has registered a new company in 2017 in the State of Kentucky. The company is called Fission Biomedical LLC. It is also listed on the Patent as the co-owner along with Transplantation Limited. Both are owned by DR. Casey:
https://patents.google.com/patent/US8372644
http://apps.sos.ky.gov/corpscans/60/0979760-06-99999-20170317-AOG-6748124-PU.PDF
The recent stock activity of TCEL coupled to the recent reinstatement of TCEL with Wyoming SOS, along with WE HAVE UNCOVERED BRAND NEW PATENTS & A BRAND NEW COMPANY (Fission Biomedical LLC and ContraVaccine LTD.) Strongly Suggesting that the research by Dr. Casey has been going full speed ahead behind the scenes.
The Reinstatement also suggests that along with all these new developments, there is news on the horizon of possible FDA approval for human trials for Therapy Cells & the possibility and bringing Mr. Casey's new company which shares TCEL Patents into the company as well maybe as an acquisition or Reverse Merger. Below is the research that would explain the current stock action and resurgence of volume and accumulation interest:
Therapy Cells, Inc. is a holding company. Their primary business focus and direction is applying Patent 8372644 and pursuing Therapy Cell related business. The company owned by Dr. Patrick Casey, Therapy Cells Limited (TCL), a New Zealand Corporation, was acquired by Therapy Cells Inc. (USA ) in August of 2011 for 3,000,000 Preferred C shares.
Therapy Cells, Inc. has been granted exclusive license to use Patent 8372644 for use in human applications. In 2013, the company had to cease trials due to lack of funding. The funding was in place in September 2015 via Soffinova Partners:
http://www.marketwired.com/press-release/therapy-cells-receives-funding-from-sofinnova-partners-advance-development-tissue-organ-otcqb-tcel-2057891.htm
The company has been quietly completing their research since! It's possible there were delays in receiving some of the funding, since it was coming from overseas (Paris), and it likely gets received as needed. Some NEW good news, just out last month from Sofinnova Partners, is that they have new funding for Biotech and Pharmaceutical companies estimated to be at least $375 million. Therapy Cell, Inc. in past PR stated that this was a long term funding agreement - as research is not a Fast process but an approach to science that requires tenacity and hard work, and the funding matter has to be out of the way which it has been during this time of dedicated silence in our opinion:
https://www.businesswire.com/news/home/20180403005874/en/Sofinnova-Partners-Launches-Healthcare-Crossover-Fund-%E2%82%AC275
Dr. Patrick Casey, who owns 3,000,000 preferred C shares via Therapy Cells, Limited (New Zealand) is also one of three beneficiary stockholders in Therapy Cells, Inc. He has been active.
In 2017 Casey was granted another NEW patent :
THIS YEAR In 2018, he applied for another new patent:
THE BIGGEST INTRIGUING NEWS IS THIS RECENT ACTIVITY: Dr. Patrick J. Casey has registered a new company in 2017 in the State of Kentucky. The company is called Fission Biomedical LLC. It is also listed on the Patent as the co-owner along with Transplantation Limited. Both are owned by DR. Casey:
https://patents.google.com/patent/US8372644
http://apps.sos.ky.gov/corpscans/60/0979760-06-99999-20170317-AOG-6748124-PU.PDF
CHARTS WORK IN ALL MARKETS - Anyone That States Otherwise
is Either Lying To Deceive You or Knows Nothing About Charting
Whatsoever! This is an Inarguable Fact ~ Struk ;-)
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
